Condition: Primary and Secondary Congenital Hypothyroidism
Biomarker: Thyroxine (T4)
The T4 assay is intended for the quantitative determination of Thyroxine (T4) concentrations in dried neonatal whole blood specimens. Measurement of T4 is used as a primary or secondary screen in the diagnosis and treatment of congenital hypothyroidism in newborns, an inborn error of thyroid hormone production.
For more information, visit Congenital Hypothyroidism
• Options of 3 hour or overnight assay protocols – Flexible timeline to fit your laboratory’s needs
• Single plate elution allows for semi-plexing with other immunoassays – Reduced microplate usage with efficient workflow
• Multi-analyte calibrators and controls in DBS format – Simplified workflow with complementary assays
For In Vitro Diagnostic Use. This device is intended for use by trained, qualified laboratory personnel.
PRODUCT ORDERING INFORMATION
SPOTCHECK® NEONATAL T4 MICROPLATE REAGENT KIT CONFIGURATIONS
|85-4000-05K/KE||5 Plate||Dried blood spot calibrators and controls, antibody coated microplates, all reagents|
|85-4000-20K/KE||20 Plate||Dried blood spot calibrators and controls, antibody coated microplates, all reagents|